vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower VAL Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist VIPS Q4 2025 Earnings EPS Surprise Lifts Sentiment Amid Modest Stock Pullback WTBA Q1 2026 Earnings EPS Beat Surprises Stock Declines First Bancorp FBNC Q1 2026 Earnings EPS Edges Past Expectations Amid Quiet Market Reaction Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain GD Q1 2026 Earnings EPS Beats Estimates by 82 Stock Rises AVNW Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter CRESY Q1 2026 Earnings Robust EPS Driven by Operational Strength and Favorable Currency Adjustments NATR Q1 2026 Earnings Strong EPS Beat Hints at Profitability Gains